Axon Enterprise vs Rolls-Royce: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Axon Enterprise Inc. (AXON)

Q3 202612 Jul – 21 Aug 2026

▲3▼1

Axon's record Q2 and raised outlook drive growth story

Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.
This is the core new event that directly lifts Axon's growth prospects and stock price.
Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.
It highlights the underlying demand strength that supports the raised outlook and long-term growth.
Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.
It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.
New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.
It is a new product development that supports the long-term growth narrative beyond current results.

August 202612 Jul – 21 Aug 2026

▲3▼1

Axon's record Q2 and raised outlook drive growth story

Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.
This is the core new event that directly lifts Axon's growth prospects and stock price.
Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.
It highlights the underlying demand strength that supports the raised outlook and long-term growth.
Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.
It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.
New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.
It is a new product development that supports the long-term growth narrative beyond current results.

Latest12 Jul – 21 Aug 2026

▲3▼1

Axon's record Q2 and raised outlook drive growth story

Record Q2 revenue and raised full-year outlook Axon reported Q2 revenue of $904 million, up 35% year over year, and raised its 2026 revenue growth guidance to 32-34% from 30-32%. This shows strong demand for its products and boosts investor confidence in future growth.
This is the core new event that directly lifts Axon's growth prospects and stock price.
Strong bookings and recurring revenue Future contracted bookings jumped 41% to $15.1 billion, and annual recurring revenue rose 39% to $1.6 billion with net revenue retention at 126%. This means customers are committing to more Axon products and services, providing predictable future income.
It highlights the underlying demand strength that supports the raised outlook and long-term growth.
Q2 earnings miss and margin pressure Despite revenue growth, adjusted earnings per share of $1.88 missed the consensus estimate of $1.89, and net income fell to $29 million from $36 million a year earlier. This shows costs are rising and profitability is under pressure, which can weigh on the stock.
It provides the main counterweight to the positive revenue news and explains why the stock dropped after earnings.
New Taser product (Apollo) on track Axon is close to finalizing its Apollo cartridge, a new Taser designed to outperform a nine-millimeter bullet, with a target release by next winter. This innovation could open new markets and drive future sales.
It is a new product development that supports the long-term growth narrative beyond current results.

Q2 202619 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

June 202619 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

19 Jun – 2 Jul 2026

▲3

Axon's AI and counter-drone boom, plus federal contract hopes, drive the stock

AI and software revenue surge Axon's AI product revenue jumped over 700% and software revenue rose 35%, pushing Q1 revenue up 34% to $807 million. Management raised full-year growth guidance to 30-32%. This shows the company's core business is growing much faster than expected, which supports a higher stock price.
This is the fundamental growth driver behind the stock's move and a new guidance raise.
Counter-drone platform Dedrone takes off Axon's Dedrone counter-drone business grew about 300% year-over-year and has already brought in more bookings than its purchase price. The 2026 World Cup is a near-term opportunity. This fast-growing new product line adds a fresh revenue stream and boosts investor excitement.
Dedrone's rapid growth is a new, concrete driver of future revenue and stock momentum.
Trump stake and ICE contract signal federal demand President Trump bought $1M-$5M of Axon stock in February, and ICE later sought a $220M Taser contract matching Axon's specs. While the contract isn't awarded and no wrongdoing is proven, the news suggests more federal business ahead, lifting the stock.
This is a major new catalyst that directly boosted the stock by 10% and points to potential federal contracts.
Political controversy and valuation risk Axon faces scrutiny over alleged involvement in a Scottsdale city council race, which could hurt its reputation with public agencies. Also, the stock trades at a very high price-to-earnings ratio near 100 and is still 30% below its peak, so any bad news could trigger sharp drops.
This is the main counterweight: reputational and valuation risks that could push the stock down despite strong growth.

Rolls-Royce Holdings PLC (RR.LSE)

Q3 202621 Jun – 2 Aug 2026

▲3▼1

Rolls-Royce profit jumps, guidance raised on defense and power demand

H1 profit surge and raised guidance Rolls-Royce's first-half operating profit jumped 46% to £2.5bn, prompting the company to raise its full-year profit guidance to £4.7–4.9bn. This strong financial performance was the main driver of the stock's rise.
The profit beat and guidance raise are the central new financial events that directly lifted the shares.
Defense and power systems growth A £15bn boost to the UK defense budget supports Rolls-Royce's £17.4bn order backlog. Meanwhile, its power systems unit benefits from a looming 100GW US power shortfall and booming data-center demand, with orders up over half and another hyperscaler deal near.
These are new, concrete demand drivers that underpin future revenue and were highlighted as key positives this period.
New nuclear deals Rolls-Royce signed new nuclear agreements in Sweden, the UK, and Japan, adding long-term revenue potential. These deals strengthen its position in the small modular reactor market and support future growth.
The nuclear deals are a fresh positive development that expands the company's long-term opportunity pipeline.
SMR sourcing and weak China luxury demand Risks remain: SMR reactor vessels must be sourced overseas, angering UK politicians and unions and potentially delaying approvals. Chinese luxury car demand is still weak, and quantum computing work is only an early-stage positive signal.
These are the main counterweights that could cap gains or delay projects, providing a balanced view.

July 202621 Jun – 2 Aug 2026

▲3▼1

Rolls-Royce profit jumps, guidance raised on defense and power demand

H1 profit surge and raised guidance Rolls-Royce's first-half operating profit jumped 46% to £2.5bn, prompting the company to raise its full-year profit guidance to £4.7–4.9bn. This strong financial performance was the main driver of the stock's rise.
The profit beat and guidance raise are the central new financial events that directly lifted the shares.
Defense and power systems growth A £15bn boost to the UK defense budget supports Rolls-Royce's £17.4bn order backlog. Meanwhile, its power systems unit benefits from a looming 100GW US power shortfall and booming data-center demand, with orders up over half and another hyperscaler deal near.
These are new, concrete demand drivers that underpin future revenue and were highlighted as key positives this period.
New nuclear deals Rolls-Royce signed new nuclear agreements in Sweden, the UK, and Japan, adding long-term revenue potential. These deals strengthen its position in the small modular reactor market and support future growth.
The nuclear deals are a fresh positive development that expands the company's long-term opportunity pipeline.
SMR sourcing and weak China luxury demand Risks remain: SMR reactor vessels must be sourced overseas, angering UK politicians and unions and potentially delaying approvals. Chinese luxury car demand is still weak, and quantum computing work is only an early-stage positive signal.
These are the main counterweights that could cap gains or delay projects, providing a balanced view.

Latest21 Jun – 2 Aug 2026

▲2▼2

Rolls-Royce wins new nuclear deals but faces UK content scrutiny

Sweden SMR contract and UK/Japan nuclear tech deals Rolls-Royce won a contract to build three small modular reactors in Sweden and signed nuclear technology agreements with the UK and Japan. These deals turn policy support into real revenue commitments, strengthening the long-term growth story and supporting the share price.
This is a new, concrete win that adds to Rolls-Royce's nuclear order book and future revenue.
Overseas sourcing for SMR reactor vessels raises political risk Rolls-Royce is buying key reactor parts from South Korea or the Czech Republic because no UK supplier can make them. This has upset UK politicians and unions, and could slow approvals or force costly changes, weighing on the SMR programme and the shares.
It is a new negative development that could delay or complicate a key growth project.
Quantum computing partnership for turbine design Rolls-Royce is working with Quantinuum and others to explore quantum computing for designing better gas turbines. If successful, this could cut development costs and improve engine performance over time, a small but positive long-term signal for the shares.
It is a new technology collaboration that could enhance future competitiveness.
China consumer weakness hits luxury car sales Rolls-Royce car sales in China have fallen as consumers there spend less on luxury goods. While the decline is less severe than for mass-market brands, it still points to weaker demand in a key market, a mild drag on sentiment for the company.
It is a new data point showing demand pressure in an important region.

2 Jul – 30 Jul 2026

▲4

Rolls-Royce Soars on Record Profit Upgrade and Booming Defense & AI Demand

UK defense budget boost lifts demand outlook The UK unveiled a £15 billion defense spending increase, raising the budget to 2.7% of GDP by 2029. This directly benefits Rolls-Royce's defense arm, which already has a £17.4 billion order backlog, by increasing future orders for military engines and services.
This is a major new demand driver for Rolls-Royce's defense business, directly boosting future revenue and profit potential.
US power shortfall opens new market for gas engines Bank of America warns of a 100-gigawatt US electricity shortfall by 2030, with data centers driving demand. Natural gas turbines are sold out, pushing developers to Rolls-Royce's gas reciprocating engines, creating a new growth avenue beyond aerospace.
This highlights a new, large addressable market for Rolls-Royce's power systems segment, driven by AI data center growth.
H1 profit jumps 46%, guidance raised sharply Rolls-Royce reported a 46% rise in first-half operating profit to £2.5 billion and raised full-year guidance to £4.7-4.9 billion, up from £4-4.2 billion. Strong performance across civil aerospace, defense, and power systems drove the beat, with free cash flow also rising.
This is the core earnings event that directly validates the company's turnaround and boosts investor confidence.
Data center orders surge, hyperscaler deal imminent Rolls-Royce's power systems unit grew organic revenue 28% and profit 72%, with the data center order book expanding by over half in H1. The CEO said another major hyperscaler deal is near, and orders are already being taken for 2028, signaling strong future growth.
This shows concrete momentum in the fast-growing data center power business, a key new profit engine.